Term
|
Definition
| Cell wall inhibitors- B lactams- widely effective, low toxicity |
|
|
Term
|
Definition
| Cell wall inhibitors- B lactams |
|
|
Term
| Imipenem/cilastatin (Primaxin) |
|
Definition
| B-Lactam, cell wall inhibitor |
|
|
Term
| Aztreonam (Azactam) IV/IM |
|
Definition
| B-lactam, cell wall inhibitors- monobactams. narrow spectrum enterobacteria aerobic gm - rods only |
|
|
Term
|
Definition
| cell wall inhibitor- not systemic, punches holes in wall. MRSA sensitive |
|
|
Term
|
Definition
| cell wall inhibitor- active against wide variety of gm +. topical only d/t nephrotoxicity potential |
|
|
Term
|
Definition
| cell wall inhibitor-topical; impetigo, eradicate nasal MRSA |
|
|
Term
|
Definition
| inhibit transpeptidase enzyme, interdere with last step in cell wall synthesis, inactive against mycobacteria, protozoa, fungi, viruses. |
|
|
Term
|
Definition
| cell wall inhibitor- B lactam, Carbapenem |
|
|
Term
|
Definition
| B Lactamase inhibitors- no significant antibacterial activity |
|
|
Term
|
Definition
| B Lactamase inhibitors- no significant antibacterial activity |
|
|
Term
|
Definition
| B Lactamase inhibitors- no significant antibacterial activity |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Benzylpenicillin- natural PCN. For non-penicllinase producing cocci (+&-), gram + bacilli, spirochetes. Meningococcal infections, syphilis, anaerobes |
|
|
Term
|
Definition
| Natural PCN- more acid stable, for oral infections |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Antistaphylococcal PCNs- for nephritis, rarely used. injected. AE= nephritis |
|
|
Term
|
Definition
| Antistaphylococcal PCNs- injected. not for nephritis |
|
|
Term
|
Definition
| Antistaphylococcal PCNs- Oral, chronic infections. Parenteral: for serious staph infections |
|
|
Term
|
Definition
| Antistaphylococcal PCNs- Oral, chronic infections. Parenteral: for serious staph infections |
|
|
Term
|
Definition
| Antistaphylococcal PCNs- Oral, chronic infections. Parenteral: for serious staph infections |
|
|
Term
|
Definition
| extended spectrum PCN. (PO/IM/IV). DOC for Listeria monocytogenes. AE maculopapular rash |
|
|
Term
|
Definition
| extended spectrum PCN (PO). Dental procedure prophylaxis, completely absorbed |
|
|
Term
|
Definition
| Antipseudomonal PCN. AE= platelet dysfunction |
|
|
Term
|
Definition
| antipseudomonal PCN, most potent |
|
|
Term
|
Definition
| PCN AE= platelet dysfunction |
|
|
Term
|
Definition
| semisynthetic B-lactam antibiotics |
|
|
Term
| PCN G substitutes that are resistant to staphylococcus B-lactamase |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Cefazolin (Ancef, Kefzol)- IM/IV |
|
Definition
| 1st gen Cephalopsprin- good for severe & bone infections. used in orthopedic surgery |
|
|
Term
|
Definition
| 2nd generation cephalosporins |
|
|
Term
| Cefoxitin (Mefoxin) IM/IV |
|
Definition
| 2nd gen cephalosporins- active against anaerobic bacteria |
|
|
Term
| Ceftriaxone (Rocephin) IM/IV |
|
Definition
| 3rd gen cephalosporins- DOC Meningitis |
|
|
Term
| Cefotaxime (Claforan) IM/IV |
|
Definition
| 3rd gen cephalosprins- DOC meningitis |
|
|
Term
|
Definition
| 4th gen cephalosporins- wide spectrum antibiotic |
|
|
Term
| DOC for treatment of serious infections caused by several gm - bugs |
|
Definition
|
|
